Results 11 to 20 of about 10,922 (238)

Evolving TRALI risk across apheresis and whole blood platelet products in the United States: An 18-year American Red Cross hemovigilance analysis. [PDF]

Transfusion
Abstract Background Transfusion‐related acute lung injury (TRALI) remains a leading cause of transfusion‐associated mortality in the United States. Donor‐based mitigation has reduced TRALI risk from plasma and apheresis platelets, but the residual risk associated with whole‐blood‐derived pooled platelets is not well defined. Study Design and Methods We
Young PP, Singh U, Webb J, Looney MR.
europepmc   +4 more sources

Transfusion-related acute lung injury (TRALI): Current understanding, challenges, and future directions. [PDF]

Saudi Med J
Kuriri FA.
europepmc   +3 more sources

Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial. [PDF]

Transfusion
Abstract Background The aim of this analysis was to quantify and compare the frequency of transfusion‐related adverse events (TRAE) in adult patients with myocardial infarction transfused with a restrictive versus liberal transfusion strategy from the Myocardial Ischemia and Transfusion (MINT) trial.
Ghafghazi S, Uhl L, Herbert B, Bertolet M, Alexander JH, Goodman SG, Raval J, Roubille F, Fordyce CB, Goldfarb M, Bainey K, de Andrade PB, Senaratne J, Bracey A, Roswell RO, Lopes R, Simon T, Steg G, Brooks MM, Hebert PC, Carson JL, Triulizi DJ, MINT Trial Investigators.   +22 more
europepmc   +2 more sources

Investigation of suspected TRALI cases in 2006–2011

Zdravniški Vestnik, 2012
Introduction: Three decades ago, transfusionrelated acute lung injury (TRALI) became an independent clinical entity. In the following years it was recognized among the most common transfusion-related major morbidity and mortality causes.
Marjeta Maček Kvanka, Marjeta Potočnik
doaj   +1 more source

Resolution of Noncardiogenic Pulmonary Oedema and Suspected Uraemic Pneumonitis in a Dog With Acute Kidney Injury Treated by Haemodialysis. [PDF]

Vet Med Sci
Noncardiogenic pulmonary oedema (suspected uraemic pneumonitis) secondary to acute kidney injury in a dog. This case suggests that noncardiogenic pulmonary oedema may have been triggered by uraemia and systemic inflammation, and that haemodialysis may have contributed to pulmonary recovery by alleviating the uraemic condition.
Kim SH, Park JH, Jeong YS, Park SY, Kim SR, Ryu MO, Choi JH, Seo KW.   +7 more
europepmc   +2 more sources

Neutrophil‐reactive autoantibodies in blood donors: Can we expect TRALI ? [PDF]

Transfusion, EarlyView.
Abstract Background Transfusion‐related acute lung injury (TRALI) is a clinical condition characterized by acute non‐cardiogenic pulmonary edema during or after transfusion. Despite several mitigation strategies, TRALI remains a leading cause of transfusion‐related deaths.
Stefanie Jehle, Darvin Preuss, Yannick Waxmann, Anja Spies-Naumann, S. Schmidt, Rick Kapur, Ulrich J. Sachs, Behnaz Bayat   +7 more
openalex   +2 more sources

Transfusion-related acute lung injury; clinical perspectives [PDF]

Korean Journal of Anesthesiology, 2015
Transfusion-related acute lung injury (TRALI) was introduced in 1983 to describe a clinical syndrome seen within 6 h of a plasma-containing blood products transfusion. TRALI is a rare transfusion complication; however, the FDA has suggested that TRALI is
Jeongmin Kim, Sungwon Na
doaj   +1 more source

Clinical Factors of Blood Transfusion-Related Acute Lung Injury and Changes in Levels of Treg-Related Cytokines

Emergency Medicine International, 2022
Objective. Analysis of clinical factors and changes in regulatory T cell (Treg)-related cytokine levels in transfusion-associated acute lung injury (TRALI). Methods.
Lifang Sun, Yu Liu
doaj   +1 more source

Crosstalk between neutrophil extracellular traps and immune regulation: insights into pathobiology and therapeutic implications of transfusion-related acute lung injury

Frontiers in Immunology, 2023
Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-associated death, occurring during or within 6 hours after transfusion.
Yi Liu, Rong Wang, Congkuan Song, Song Ding, Yifan Zuo, Ke Yi, Ning Li, Bo Wang, Qing Geng   +8 more
doaj   +1 more source

Tirofiban interferes with antibody-mediated transfusion-related acute lung injury by inhibiting platelet-neutrophil binding

Zhongguo shuxue zazhi, 2022
Objective To explore the feasibility of tirofiban, a platelet surface glycoprotein (GP)Ⅱb/Ⅲa receptor antagonist intervene in transfusion-related acute lung injury (TRALI), by inhibiting platelet activation and by preventing platelet and neutrophil ...
Xin YUAN, Yunhong YU, Congchao QIAO, Pan SUN, Na SU, Peng JIANG, Fangzhao LIN   +6 more
doaj   +1 more source